Fibula HEALTH’s Post

FOR CLINICIANS ONLY: FSR-GSCA is pleased to announce its next FSR-GCA Sarcoidosis Journal Club CME, on May 15, 2024, at 4:00 - 5:00pm CST. We are honored to have FSR Clinic Alliance Founding Member, Yale School of Medicine, co-hosting this virtual session. Join experts, fellows, and residents at this virtual event to gain knowledge in advancements of sarcoidosis and awareness of current research findings. May 2024 Publications to be discussed: Cardiac sarcoidosis: systematic review of the literature on corticosteroid and immunosuppressive therapies. https://loom.ly/wFCWsSE

When considering a central lab for your pediatric clinical trial, it’s important to research to ensure they have the right tools for the job. At ACM Global Laboratories, we know the adoption of the Greiner MiniCollect system in pediatric clinical trials is a critical advancement that aligns with the ethical and practical demands of modern medical research. Learn more: https://lnkd.in/gzAcCiNF #PediatricClinicalTrials #ClinicalResearch

FOR CLINICIANS ONLY: FSR-GSCA is pleased to announce its next FSR-GCA Sarcoidosis Journal Club CME, on May 15, 2024, at 4:00 - 5:00pm CST. We are honored to have FSR Clinic Alliance Founding Member, Yale School of Medicine, co-hosting this virtual session. Join experts, fellows, and residents at this virtual event to gain knowledge in advancements of sarcoidosis and awareness of current research findings. May 2024 Publications to be discussed: Cardiac sarcoidosis: systematic review of the literature on corticosteroid and immunosuppressive therapies. https://loom.ly/wFCWsSE

FOR CLINICIANS ONLY: FSR-GSCA is pleased to announce its next FSR-GCA Sarcoidosis Journal Club CME, on May 15, 2024, at 4:00 - 5:00pm CST. We are honored to have FSR Clinic Alliance Founding Member, Yale School of Medicine, co-hosting this virtual session. Join experts, fellows, and residents at this virtual event to gain knowledge in advancements of sarcoidosis and awareness of current research findings. May 2024 Publications to be discussed: Cardiac sarcoidosis: systematic review of the literature on corticosteroid and immunosuppressive therapies. https://loom.ly/wFCWsSE

Since Monday, we have been celebrating Clinical Trials Day all week long - honoring the trailblazers among us! At MAC Clinical Research, we’re proud to be at the forefront of clinical research, driving medical advancements to improve quality of life. From our memory clinics established in 1988 to our cutting-edge psychedelic studies, we have grown over the years to provide a truly diverse range of services and capabilities. We wouldn’t have been able to do this without our trailblazers; our clinical researchers, our sponsors, and our participants. Our clinical research professionals at MAC Clinical Research are at the heart of our company. Their support and dedication have enabled us to excel in clinical trials, resulting in hope and better health outcomes for patients and their families. Our sponsors are integral to clinical trials. Their pioneering work in research helps bring new medicines to market ensuring a better future for everyone. And lastly, nothing would be possible without the continuous commitment and invaluable contributions of our study participants. We want to thank all of the people behind clinical trials. They are the modern-day pioneers who are shaping the future of healthcare. Contact us to find out how our professional trailblazers and robust participant database can contribute to your clinical research: https://lnkd.in/gBY-DMzx #ClinicalTrialsDay #Trailblazers #MedicalResearch #Innovation #HealthAdvancement #MAC #PioneersInResearch

FOR CLINICIANS ONLY: FSR-GSCA is pleased to announce its next FSR-GCA Sarcoidosis Journal Club CME, on May 15, 2024, at 4:00 - 5:00pm CST. We are honored to have FSR Clinic Alliance Founding Member, Yale School of Medicine, co-hosting this virtual session. Join experts, fellows, and residents at this virtual event to gain knowledge in advancements of sarcoidosis and awareness of current research findings. May 2024 Publications to be discussed: Cardiac sarcoidosis: systematic review of the literature on corticosteroid and immunosuppressive therapies. https://loom.ly/wFCWsSE

Participating in an endometriosis clinical trial can be a powerful way to advance medical research and improve care. Here's what you need to know to get started: 🔷 Understand the purpose - Clinical trials are essential for testing new treatments and improving our understanding of endometriosis. 🔷 Assess your eligibility - Check the criteria based on age, health, and medical history. 🔷 Learn the process - You’ll be involved in regular visits, treatments, and monitoring over the study period. 🔷 Informed consent - You’ll review detailed information about the study’s risks and benefits before enrolling. 🔷 Discuss concerns - Communication with the research team about any questions or concerns you may have throughout the process is vital. Joining a clinical trial is a unique opportunity to access innovative treatments while contributing to groundbreaking medical research. Don’t hesitate to get involved and be part of the solution! 🙌 #skycrng #endometriosisawareness #clinicaltrials #womenshealth #medicalresearch

I am pleased to share this systematic review methodology focused on diagnostic accuracy studies, developed in collaboration with the team from the Research Unit of Nursing Science Campus Bio-Medico University of Rome. This study is of particular relevance given the importance of diagnostic accuracy studies in the context of clinical practice. The specific methodology aims to consolidate and critically analyze existing evidence, thereby contributing to informed clinical decisions based on solid evidence. #DiagnosticAccuracy #SystematicReview #NursingScience #EvidenceBasedPractice https://lnkd.in/dPfBd8Qe

On this World Clinical Trials Day, we reflect on the pioneering spirit that drives clinical research and its profound impact on advancing medicine and improving lives. Today marks the anniversary of what is considered to be the first randomized clinical trial, conducted by James Lind in 1747 aboard HMS Salisbury. He not only found a cure for scurvy but also established the principles of clinical research that have saved countless lives since. As we commemorate this day, we recognize the visionary spirit that underpins the clinical research community and are proud of the essential “bench to bedside” role Nucleus Network plays in bridging the gap between innovative laboratory discoveries and tangible patient treatments. May 20 is a day to celebrate the progress we’ve made and the future we’re shaping. It’s a reflection of the tireless efforts of clinical research professionals and their commitment to advancing healthcare, serving as a reminder of the importance of clinical trials in achieving that goal. It is also a day to honor the incredible dedication of volunteers who are instrumental in this journey. Their commitment provides researchers with invaluable data, helping to uncover new treatments and improve healthcare for all. We are profoundly thankful for their selfless participation, which accelerates medical progress. Together, let’s honor the past, celebrate the present, and look forward to a future where clinical trials continue to bring forth life-changing discoveries. #WorldClinicalTrialsDay #ClinicalTrials #Biopharma #phase1trials #medicalinnovation

There are very few medical devices specifically developed for rare diseases and children, so-called 'paediatric and orphan devices'. Many orphan devices provide essential functions for patients with rare diseases, their carers, and the healthcare professionals using them. At the same time, many patients and carers express a substantial unmet need for new paediatric devices for their conditions. As such, this initiative will support the development of paediatric and orphan devices via two steps. The EC-funded DeCODe (development of child and orphan devices) consortium is set to change this. DeCODe - which Trinity College is a member - aims to catalyse innovation and address the unique healthcare needs of people living with rare diseases (PLWRD), specifically children. This collaborative group, comprising clinicians, researchers, industry experts, and regulatory authorities, will develop a platform for developing safe and effective paediatric and orphan medical devices.  The project is led at Trinity by Dr Tom Melvin, Associate Professor of Medical Device Regulatory Affairs at Trinity College Dublin School of Medicine. You can read more on this new #TrinityResearch story here: https://lnkd.in/ehDcgUV2 #researchMATTERS